2019
DOI: 10.1096/fasebj.2019.33.1_supplement.446.6
|View full text |Cite
|
Sign up to set email alerts
|

In‐Vitro Estradiol Treatment Increases the Expression of Metabotropic Glutamate Receptors in Embryonic Dopamine Neurons

Abstract: Sex differences in the manifestation, prevalence, and progression of dopamine‐related diseases have been documented, suggesting a role of gonadal hormones (Bodzean et al., 2014; Kokras and Dalla, 2014). Although dopamine neurons are sensitive to estradiol (E2), main estrogen metabolite in women, it is uncertain how estradiol affects the function and survival of dopamine neurons. Eight metabotropic glutamate receptor subtypes (mGluR1‐8) have been identified and classified in three different groups according to … Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles